Clinical relevance of β2-glycoprotein-I plasma levels in Antiphospholipid Syndrome (APS)

Current Rheumatology Reports

Volumn 16, Issue 6, 2014, Pages

  Banzato, Alessandra ^a   Pengo, Vittorio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Antiphospholipid antibodies; Antiphospholipid syndrome; APS; Beta 2 glycoprotein I; Plasma levels; Thrombosis

Indexed keywords

ANTIGEN; BETA2 GLYCOPROTEIN 1; BETA2 GLYCOPROTEIN 1 ANTIGEN; UNCLASSIFIED DRUG; PHOSPHOLIPID ANTIBODY;

ANTIGEN FUNCTION; ANTIPHOSPHOLIPID SYNDROME; BINDING AFFINITY; BINDING SITE; BLOOD LEVEL; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE ASSOCIATION; HISTORY OF MEDICINE; HUMAN; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; OUTCOME ASSESSMENT; PERSONAL EXPERIENCE; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; BLOOD; IMMUNOLOGY; THROMBOSIS;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; HUMANS; THROMBOSIS;

EID: 84901596072     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-014-0424-9     Document Type: Review

References (26)

1. Schultze HE. Glycoproteins of human plasma. Bull Schweiz Akad Med Wiss. 1961;17:77-91.
2. Schultze HE,Mahling A. On the problem of the chemical structure of plasma proteins. Bibl Haematol. 1961;12:197-224.
3. Aoyama Y, Chan YL, Wool IG. The primary structure of rat beta 2-glycoprotein I. Nucleic Acids Res. 1989;17:6401.
4. Lozier J, Takahashi N, Putnam FW. Complete amino acid sequence of human plasma beta 2-glycoprotein I. Proc Natl Acad Sci U S A. 1984;81:3640-4. (Pubitemid 14087780)
5. Bouma B, de Groot PG, van den Elsen JM, et al. Adhesion mechanism of human beta(2)-glycoprotein I to phospholipids based on its crystal structure. EMBO J. 1999;18:5166-74. (Pubitemid 29465567)
6. Schwarzenbacher R, Zeth K, Diederichs K, et al. Crystal structure of human beta2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome. EMBO J. 1999;18:6228-39. (Pubitemid 29533227)
7. Shi T, Iverson GM,Qi JC, et al. Beta 2-Glycoprotein I binds factor XI and inhibits its activation by thrombin and factor XIIa: loss of inhibition by clipped beta 2-glycoprotein I. Proc Natl Acad Sci U S A. 2004;101:3939-44. (Pubitemid 38381081)
8. Yasuda S, Atsumi T, Ieko M, Koike T. Beta2-glycoprotein I, anti-beta2-glycoprotein I, and fibrinolysis. Thromb Res. 2004;114:461-5.
9. Wurm H, Beubler E, Polz E, Holasek A, Kostner G. Studies on the possible function of beta 2-glycoprotein-I: influence in the triglyceride metabolism in the rat. Metabolism. 1982;31:484-6. (Pubitemid 12155456)
10. Hasunuma Y, Matsuura E, Makita Z, Katahira T, Nishi S, Koike T. Involvement of beta 2-glycoprotein I and anticardiolipin antibodies in oxidatively modified low-density lipoprotein uptake by macrophages. Clin Exp Immunol. 1997;107:569-73. (Pubitemid 27102148)
11. Mori T, Takeya H, Nishioka J, Gabazza EC, Suzuki K. beta 2-Glycoprotein Imodulates the anticoagulant activity of activated protein C on the phospholipid surface. Thromb Haemost. 1996;75:49-55. (Pubitemid 26051194)
12. Ieko M, Ichikawa K, Triplett DA, et al. Beta2-glycoprotein I is necessary to inhibit protein C activity by monoclonal anticardiolipin antibodies. Arthritis Rheum. 1999;42:167-74. (Pubitemid 29042583)
13. Agar C, de Groot PG, Morgelin M, et al. beta(2)-glycoprotein I: a novel component of innate immunity. Blood. 2011;117:6939-47.
14. Pozzi N, Acquasaliente L, Frasson R, et al. beta2-Glycoprotein I binds to thrombin and selectively inhibits the enzyme procoagulant functions. J Thromb Haemost. 2013;11:1093-102.
15. Vlachoyiannopoulos PG, Beigbeder G, Dueymes M, et al. Antibodies to phosphatidylethanolamine in antiphospholipid syndrome and systemic lupus erythematosus: their correlation with anticardiolipin antibodies and beta 2 glycoprotein-I plasma levels. Autoimmunity. 1993;16:245-9. (Pubitemid 24111621)
16. McNally T, Mackie IJ, Machin SJ, Isenberg DA. Increased levels of beta 2 glycoprotein-I antigen and beta 2 glycoprotein-I binding antibodies are associated with a history of thromboembolic complications in patients with SLE and primary antiphospholipid syndrome. Br J Rheumatol. 1995;34:1031-6. (Pubitemid 26013504)
17. McNally T, Mackie IJ, Machin SJ, Isenberg DA. Elevated levels of beta 2 glycoprotein-I (beta 2 GPI) in antiphospholipid antibody syndrome are due to increased amounts of beta 2 GPI in association with other plasma constituents. Blood Coagul Fibrinolysis. 1995;6: 411-6.
18. Balasubramanian K, Killion JJ, Schroit AJ. Estimation of plasma beta-2-glycoprotein levels by competitive ELISA. Thromb Res. 1998;92:91-7. (Pubitemid 28481388)
19. Mehdi H, Aston CE, Sanghera DK, Hamman RF, Kamboh MI. Genetic variation in the apolipoprotein H (beta2-glycoprotein I) gene affects plasma apolipoprotein H concentrations. Hum Genet. 1999;105:63-71. (Pubitemid 29396966)
20. Yasuda S, Tsutsumi A, Chiba H, et al. beta(2)-glycoprotein I deficiency: prevalence, genetic background and effects on plasma lipoprotein metabolism and hemostasis. Atherosclerosis. 2000;152:337-46.
21. Mehdi H, Manzi S, Desai P, et al. A functional polymorphism at the transcriptional initiation site in beta2-glycoprotein I (apolipoprotein H) associated with reduced gene expression and lower plasma levels of beta2-glycoprotein I. Eur J Biochem. 2003;270: 230-8. (Pubitemid 36123967)
22. Song KS, Kim HK. Prevalence of beta2-glycoprotein I antibody in patients with liver cirrhosis: relationship with beta2-glycoprotein I plasma levels and thrombosis. Clin Appl Thromb Hemost. 2004;10: 183-6. (Pubitemid 38490088)
23. Lin F, Murphy R, White B, et al. Circulating levels of beta2-glycoprotein I in thrombotic disorders and in inflammation. Lupus. 2006;15:87-93. (Pubitemid 43345333)
24. de Laat B, de Groot PG, Derksen RH, et al. Association between beta2-glycoprotein I plasma levels and the risk of myocardial infarction in older men. Blood. 2009;114:3656-61.
25. Gries A, Putz-Bankuti C, Stauber RE, Haditsch B, Stojakovic T. Beta2-glycoprotein-I plasma levels in liver cirrhosis. Clin Chim Acta. 2009;403:257-8.
26. Banzato A, Frasson R, Acquasaliente L, et al. Circulating β2 glycoprotein I-IgG anti-β2 glycoprotein I immunocomplexes in patients with definite antiphospholipid syndrome. Lupus. 2012;21(7):784-6.